Thioridazine Hydrochloride Tablet, Film Coated
Product Images NDC 51079-565

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Thioridazine Hydrochloride (NDC 51079-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thioridazine Hydrochloride 10 mg Tablets Unit Carton Label (Image 01)

FDA Label Image

Unit Carton (Image 02)

Thioridazine Hydrochloride Tablets are a medicine that contains 10mg of Thiordazne hydrochloride, USP. The recommended dosage instructions can be found with the accompanying prescription information. These tablets are film-coated and should be stored between 20-25°C while being protected from light. This medicine is manufactured by Mylan Pharmaceuticals Inc. in the United States, and is also made in India. The corresponding code is MH/DRUGS/25NKD/B9, while the NDC number for this product is 51079-565-20.*

FDA Label Image

Thioridazine Hhydrochloride 25 mg Tablets Unit Carton Label (Image 03)

Thioridazine Hydrochloride Tablets, USP are a type of medication containing 25mg of Thioridazine hydrochloride. The recommended dosage is described in the attached prescribing information. The pills come in a sealed container that must be protected from light and kept at a temperature of 20 to 25 degrees Celsius. They have been manufactured by Mylan Pharmaceuticals Inc. at their manufacturing facility located in Morgantown, West Virginia, USA.*

FDA Label Image

Unit Carton (Image 04)

Thioridazine Hydrochloride Tablets, USP is a medication used for treating mental disorders. It contains 50mg of Thioridazine hydrochloride per coated tablet. The typical dosage of the medication should be obtained from the prescribing information included with the medication. It's essential to keep the medication at a temperature between 20 to 25°C (68°F to 77°F) and protect it from light. The manufacturer of the drug is Mylan Pharmaceuticals Inc., which is located in Morgantown, WV 26505 USA.*

FDA Label Image

Thioridazine Hydrochloride 50 mg Tablets Unit Carton Labels (Image 05)

This is a description of medication in tablet form with the ID number IDC 51079-5:0. The medication is intended for the treatment of severe neuropsychiatric conditions. Each bottle of the medication contains 100 tablets with each tablet having a size of 9 mm. The active ingredient in the medication is Thioridazine Hydrochloride which is present in a strength of 100mg per tablet. The medication should be used only under the guidance of a prescribing physician. The tablets should be stored at a temperature range of 20° to 25° Celsius and protected from light. The manufacturer of the medication is not mentioned in the text.*

FDA Label Image

Thioridazine Hydrochloride 100 mg Tablets Unit Carton Label (Image 06)

This is a warning label for a drug packaging unit. It is not child-resistant and is intended for institutional use only. The label advises users to keep the drug out of reach of children, and notes that the container provides light resistance. There is a window on the container indicating the lot number and expiration date of the drug. The product is made by Mylan and manufactured in Rockford, IL, USA.*

FDA Label Image

Unit Carton (Image 07)

This is a drug package designed for institutional use only, and it is not child-resistant. It is important to keep all drugs out of reach of children. The container is light-resistant and displays lot number and expiration date on the provided window. The manufacturer is Mylan, located in Rockford, USA. No information is available regarding the product inside the package.*

FDA Label Image

Unit Carton (Image 08)

This text is a set of instructions and warnings regarding a medication packaging. The packaging is not child-resistant and intended for institutional use only. It is important to keep the medication out of reach of children. The container provides protection against light. The instructions also suggest checking the lot number and expiration date, which can be found in a window. The medication appears to be manufactured by Mylan, and the address provided is in Rockford, Illinois. However, it is not clear what drug this packaging is for.*

FDA Label Image

Image 09

This is a package warning label for Mylan® medication. It states that the package is not child-resistant and is intended only for institutional use. The warning advises to keep the medication out of the reach of children. The container provides light-resistance and the lot number and expiration date can be found on the window. The text also includes the address of the manufacturer, which is Mylan® located in Rockford, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.